Shree Pacetronix Ltd manufactures and exports Implantable Cardiac Pacemakers.Product Profile: Company deals in 3 major products viz, Pacemakers, Pacing Leads, Pacing System which are further bifurcated as: Ventralite 940+/ Tiranga, Pinnacle-8820, Tiranga -302, Pinnacle-R-SSIR-Model-29, Trinity-R, Smart - E, Atrial-J-Bipolar-Lead-3851-VB, Introducer, Zeus -1, Is1 Bipolar Lead 3851 Vb, Screw-in Lead P12,...
Shree Pacetronix has received a Detailed Public Statement regarding an open offer by promoter Akash Sethi and other promoter group members. This mandatory offer was triggered by a preferential share and warrant allotment to the acquirer totaling ₹2.43 Crore. The open offer aims to acquire up to 9.75 lakh equity...
Shree Pacetronix Limited will hold its 37th Annual General Meeting virtually on September 3, 2025, at 1:00 PM IST. This allows shareholders to participate remotely in company business. For voting eligibility, August 27, 2025, is the cut-off date. Remote e-voting begins August 31, 2025, at 9:00 AM and ends September...
Shree Pacetronix is reaching out to shareholders with physical shares, urging them to update mandatory KYC details including PAN, contact info, bank details, and nomination. This is vital because folios without these updated details will face restrictions: they cannot lodge grievances or receive any payments, like dividends, electronically until compliance....
Shree Pacetronix Ltd. has announced its 37th Annual General Meeting (AGM) will be held on September 3rd via video conferencing. The Annual Report for FY 2024-25 and the AGM notice are accessible on the company's website. These documents are being sent electronically to shareholders with registered email addresses. For those...
Shree Pacetronix Limited has announced the publication of its standalone and consolidated unaudited financial results for the quarter. The company's Board of Directors formally approved these results during their meeting. This release provides crucial financial transparency, offering shareholders a vital update on the company's recent performance. Investors should closely examine...
